Home LiteratureArticle Details
PMID: 12707046 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

The American journal of pathology ·Vol. 162 ·No. 5 ·2003-05-00 ·Pages 1623-7

Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avíla J, Jones PK, Castellani RJ, Smith MA, Perry G

Abstract

Biochemical studies show that phosphorylated tau, like that found in paired helical filaments (PHFs), does not promote microtubule assembly leading to the view that PHF formation leads to microtubule deficiency in Alzheimer's disease (AD). However, although this issue is one of the most important aspects to further understanding the cell biology of AD, no quantitative examination of microtubule diminution in AD and its relationship with PHFs has been performed. To examine this issue directly, we undertook a morphometric study of brain biopsy specimens from AD and control cases. Ultrastructural analysis of neurons was performed to compare the microtubule assembly state in neurons of diseased and control cases and to examine the effect of PHF accumulation. We found that both number and total length of microtubules were significantly and selectively reduced in pyramidal neurons from AD in comparison to control cases (P = 0.000004) but that this decrement in microtubule density was surprisingly unrelated to PHFs (P = 0.8). Further, we found a significant age-dependent decrease in microtubule density with aging in the control cases (P = 0.016). These findings suggest that reduction in microtubule assembly is not dependent on tau abnormalities of AD and aging.

MeSH Terms
Aged Aging/physiology Alzheimer Disease/pathology Biopsy Brain/pathology Brain Neoplasms/pathology Female Humans Hydrocephalus/pathology Male Microscopy, Electron Microtubules/pathology,ultrastructure Middle Aged Neurons/pathology Pyramidal Cells/pathology tau Proteins/metabolism
Chemicals
tau Proteins
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Cash Adam D
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. [email protected]
Aliev Gjumrakch
Siedlak Sandra L
Nunomura Akihiko
Fujioka Hisashi
Zhu Xiongwei
Raina Arun K
Vinters Harry V
Tabaton Massimo
Johnson Anne B
Paula-Barbosa Manuel
Avíla Jesus
Jones Paul K
Castellani Rudy J
Smith Mark A
Perry George
References (21)
21 references, click to expand
  1. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.
    Ann Neurol. 1991 Oct;30(4):572-80 PMID: 1789684
  2. Structural correlates of cognition in dementia: quantification and assessment of synapse change.
    Neurodegeneration. 1996 Dec;5(4):417-21 PMID: 9117556
  3. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress.
    Acta Neuropathol. 1996;91(1):1-5 PMID: 8773139
  4. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.
    Am J Pathol. 2001 Feb;158(2):373-9 PMID: 11159174
  5. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.
    Ann Neurol. 1990 May;27(5):457-64 PMID: 2360787
  6. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7 PMID: 3088567
  7. Oxidative damage is the earliest event in Alzheimer disease.
    J Neuropathol Exp Neurol. 2001 Aug;60(8):759-67 PMID: 11487050
  8. Quantitative assessment of cortical synaptic density in Alzheimer's disease.
    Neurobiol Aging. 1990 Jan-Feb;11(1):29-37 PMID: 2325814
  9. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.
    J Neurosci. 1999 Mar 15;19(6):1959-64 PMID: 10066249
  10. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
    J Neuropathol Exp Neurol. 1996 Oct;55(10):1023-5 PMID: 8857998
  11. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.
    Proc Natl Acad Sci U S A. 1983 Oct;80(19):6126-30 PMID: 6577472
  12. A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease.
    Brain Res. 1987 Aug 4;417(1):139-42 PMID: 3620973
  13. Life span and synapses: will there be a primary senile dementia?
    Neurobiol Aging. 2001 May-Jun;22(3):347-8; discussion 353-4 PMID: 11378236
  14. Human brain tubulin purification: decrease in soluble tubulin with age.
    Neurochem Res. 1985 Jan;10(1):1-18 PMID: 3982586
  15. Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.
    Acta Neuropathol. 1996;91(3):226-35 PMID: 8834534
  16. Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia.
    Acta Neuropathol. 1967 May 5;8(3):276-84 PMID: 6039977
  17. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic.
    Am J Pathol. 1996 Feb;148(2):415-26 PMID: 8579105
  18. Amyloid precursor protein in senile plaques of Alzheimer disease.
    Lancet. 1988 Sep 24;2(8613):746 PMID: 2901596
  19. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.
    J Neuropathol Exp Neurol. 2000 Nov;59(11):1011-7 PMID: 11089579
  20. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  21. Mitochondrial abnormalities in Alzheimer's disease.
    J Neurosci. 2001 May 1;21(9):3017-23 PMID: 11312286
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2003-05-00
Pages
1623-7
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1851211
Subset
IM
Grants
NIA NIH HHS · P50 AG016570 · United States
NINDS NIH HHS · R01 NS038648 · United States
NINDS NIH HHS · NS38648 · United States
NIA NIH HHS · P50AG16570 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]